Banner - Collaborative Care Symposium

News
Media
Conferences
Blog
Publications
Partners
Resources
Subscribe
CE

Navneet Puri, PhD

Articles by Navneet Puri, PhD

Pipeline: Presbyopia, night vision disturbance up next for Vyluma

ByNavneet Puri, PhD,Gretchyn M. Bailey, NCLC, FAAO, Editor in Chief, Content Channel Director,Brooke Henson, Editor

July 24th 2021

First Vyluma product tackles pediatric myopia

ByNavneet Puri, PhD,Gretchyn M. Bailey, NCLC, FAAO, Editor in Chief, Content Channel Director,Brooke Henson, Editor

July 23rd 2021

Vyluma pipeline focuses on refractive error

ByNavneet Puri, PhD,Gretchyn M. Bailey, NCLC, FAAO, Editor in Chief, Content Channel Director,Brooke Henson, Editor

July 22nd 2021

Nevakar spins off ophthalmic-only company Vyluma

ByGretchyn M. Bailey, NCLC, FAAO, Editor in Chief, Content Channel Director,Navneet Puri, PhD,Brooke Henson, Editor

June 1st 2021

A new ophthalmic-only pharma company was formed when Nevakar spun off its pipeline of ocular drugs.

Latest Updated Articles

Pipeline: Presbyopia, night vision disturbance up next for Vyluma
Published: July 24th 2021 | Updated:
First Vyluma product tackles pediatric myopia
Published: July 23rd 2021 | Updated:
Nevakar spins off ophthalmic-only company Vyluma
Published: June 1st 2021 | Updated:
$Vyluma pipeline focuses on refractive error$
Vyluma pipeline focuses on refractive error
Published: July 22nd 2021 | Updated:

Trending on Optometry Times - Clinical News & Expert Optometrist Insights

Takeaways from this week in optometry: October 27 - October 31

AAOpt 2025 recap: ODs provide new clinical findings on dry eye

Regeneron receives another CRL for its Eylea 8 mg

Application period opens for 2026 Golden Opportunity Award to support emerging optometrists

© 2025 MJH Life Sciences^®

All rights reserved.